Cape Verde vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Cape Verde
100.0%
in 2024
Mongolia
100.0%
in 2024
Cape Verde rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cape Verde
- Mongolia
How they compare
Cape Verde currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 6 times across 13 shared years of data; in 2005 it was Mongolia ahead.
Cape Verde ranks 1st and Mongolia ranks 1st of 144 countries.
Across the 3 decades both report, Cape Verde averaged higher in 1 and Mongolia in 1.
Head to head by decade
| Decade | Cape Verde | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 93.6% | 72.6% | 21.0% | Cape Verde |
| 2020s | 98.2% | 100.0% | 1.8% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cape Verde or Mongolia?
- Cape Verde, at 100.0% against 100.0% in Mongolia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cape Verde and Mongolia?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Mongolia?
- 13 years are reported by both, from 2005 to 2024.
- How do Cape Verde and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cape Verde ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.